Community Health System’s Post

🚨Big News!🚨 Boca Raton Regional Hospital, part of Baptist Health, has received an unprecedented $32 million grant from The Marcus Foundation – their largest gift ever! This transformative gift will propel the Marcus Neuroscience Institute to new heights within innovation in healthcare, expanding programs for brain health and conditions like Alzheimer's, Parkinson's, and brain tumors. From groundbreaking technology to recruiting world-class clinician-scientists, this grant cements our hospital’s position as a leader in neurological care. We are profoundly grateful to Bernie and Billi Marcus for their commitment to elevating healthcare for our community and beyond. Learn more: https://lnkd.in/eEQA2gCt

🌟 Spotlight on Dr. Greer Waldrop! 🌟 We're excited to highlight Dr. Greer Waldrop from The University of California, San Francisco, one of the recipients of the FSR Sarcoidosis Research Fellowship Grant. Her project, titled "Defining Neurosarcoidosis: From Disease Activity to the CNS Transcriptome," is set to revolutionize our understanding of neurosarcoidosis. Dr. Waldrop's research aims to fill crucial gaps in the field by creating a standardized framework for classifying disease activity and conducting the first-ever transcriptomic analysis from the central nervous system. This groundbreaking work will enhance our understanding of neurosarcoidosis and pave the way for better diagnostic and therapeutic strategies. Join us in celebrating Dr. Waldrop's dedication to advancing sarcoidosis research and the significant impact her work will have on patients' lives. 🎉 #Neurosarcoidosis #SarcoidosisResearch #FSRFellowship #InnovativeResearch #StopSarcoidosis

Thanks to Gift of Life, students at Howard University College of Medicine in Washington, D.C. are receiving specialized training that was developed for physicians in determining brain death. Gift of Life Institute, an affiliate of Gift of Life Donor Program, worked with experts in neurology and neurocritical care to create an innovative program that combines virtual reality simulation training and eLearning to provide a novel interactive educational experience. The Institute collaborated with Maryland-based organ procurement organization Infinite Legacy to establish a partnership with the university’s College of Medicine as part of Gift of Life’s commitment to increasing diversity in organ transplantation and donation. Brain death is rare, so it is essential that future physicians have the skills and confidence to conduct the required tests and explain test results to a patient’s family in a way that is easy to understand. Learn more at https://ow.ly/HAvW50UFnut

Extremely happy and grateful to see my work, as an annotator, being published. The results and analysis of Brain Tumor Segmentation - Metastases (BraTS-METS) Challenge 2023 is now on arXiv! Article: https://lnkd.in/dJgwZvBu

The Clinical Institutes at Providence Swedish are leading research and innovation. Whether it is studying innovative devices to control post partum hemorrhage at the Women and Children's Institute, using holographic imaging to enhance the safety of neurosurgical procedures at the Neuroscience Institute, non-invasive destruction of liver tumors at the Swedish Cancer Institute/ Digestive Health Institute or leading edge grafts for aortic aneurysm repair at the Heart and Vascular Institute ---- we have a commitment to seeking and creating new and better ways to care for our patients. In addition to exploring new treatments, our clinical research teams are studying the application of new therapies to devastating diseases - like our trials of CAR-T cell therapy in Systemic Lupus Erythematosus and Multiple Sclerosis. #SwedishCancerInstitute #SwedishNeuroscienceInstitute #SwedishDigestiveHealthInstitute #SwedishHeartandVascularInstitute #SwedishWomenandChildrensInstitute #SwedishMedicalCenter

Cure Alzheimer's Fund has expanded its Research Leadership Group by welcoming six distinguished scientists dedicated to advancing Alzheimer's disease research. These experts bring cutting-edge expertise to guide the organization's strategic research initiatives. The newly appointed members represent premier institutions including Harvard Medical School, Mount Sinai, Massachusetts General Hospital, and Mayo Clinic. Their collective research spans critical areas like genetic mechanisms, neurovascular function, microbiome interactions, and neurodegeneration pathways. Key appointments include Dr. Laura Cox, investigating microbiome roles in neurologic diseases, and Dr. Alison Goate, a pioneering genetics researcher who has identified numerous disease-causing variants. Dr. Teresa Gomez-Isla will contribute insights into early brain changes associated with Alzheimer's. Since 2004, Cure Alzheimer's Fund has distributed over $219 million in research grants, supporting innovative approaches to understanding and potentially treating this devastating condition. CEO Meg Smith emphasized the Research Leadership Group's critical role in directing funding toward the most promising scientific avenues. These distinguished researchers represent hope in the ongoing fight against Alzheimer's, bringing unprecedented expertise to accelerate breakthrough discoveries. #AlzheimerResearch #MedicalInnovation #Neuroscience

Horse Race 4Brain: Innovating for Brain Health While Developing New Revenue Streams and Sustainable Partnerships. In a world where 1 in 3 individuals will face a brain disorder such as Dementia, Epilepsy, Stroke, or Alzheimer's during their lifetime, the disparity in funding towards brain research is striking. Currently, only 1 in 10 of all research funds are allocated to this vital area. The Horse Race 4Brain presents an innovative concept designed to address this challenge. It stands as a testament to how unique events can play a crucial role in raising awareness and generating resources for brain research. This event is not just about the thrill of the race; it's a strategic initiative that merges entertainment with opening new revenue streams, attracting new clients, and creating new customer engagement opportunities. This initiative exemplifies our commitment to innovative solutions and demonstrates the potential of unique concepts. It's an opportunity to observe how diverse strategies can contribute to the greater good, aligning with our consultancy ethos of pioneering change and impactful collaboration. #largeevents #eventproduction #consultingexperts

We are excited to announce a major breakthrough in neurotechnology! Grey Matter Neurosciences, a company supported in part by OBI, has secured the licensing of innovative ultrasound technology built at the Sunnybrook Research Institute. This $14 million seed financing round, led by the Wittington Innovation Fund, also includes contributions from TIAP - Toronto Innovation Acceleration Partners and the Ontario Centre of Innovation. This funding will drive the development of a revolutionary ultrasound headset and the initiation of clinical trials for Alzheimer's patients.   Dr. Tom Mikkelsen, OBI's President and Scientific Director, shared: “As a catalyzer in the brain health space since 2010, OBI has always espoused a 'team science' approach to promoting neuroscience research, accelerating commercialization, and enhancing care by connecting researchers, clinicians, industry, patients, and their advocates to improve the lives of those living with brain disorders. As such, we saw it as close to mission-critical to support Grey Matter Neurosciences in their work to restore brain function to seniors impacted by Alzheimer's disease and other dementias through the unique power of focused ultrasound.”   🧠 Learn more: https://lnkd.in/gS-kUdtQ   #AlzheimersAwarenessMonth #Neurotechnology #AlzheimersResearch #BrainHealth #HealthTech

✨ Exploring the Phenomenon of Dreaming During Surgical Anesthesia: The Shull-Chow Method✨ Thank you, Miranda Shull, for your fascinating APP Grand Round Lecture! Dreaming during surgical anesthesia is a fascinating and complex phenomenon that has intrigued anesthesia providers for years. Despite being frequently observed, it remains poorly understood. The Shull-Chow method was born out of extensive trial and error in search of the perfect anesthesia cocktail that could elicit dreams. By incorporating EEG guidance to precisely measure the depth of anesthesia and dream-associated morphology, a total IV anesthetic utilizing a combination of propofol and remifentanil has emerged as the key. The titration of propofol during pre-emergence plays a crucial role in facilitating access to the dream state, while remifentanil ensures a smooth transition towards the end of surgery without causing patient movement. A groundbreaking dream study focused on breast cancer surgical patients sought to characterize the type of dream content and dream structure patterns experienced during anesthesia. By examining the presence, perceived duration, and emotional content of dreaming, researchers have shed light on this intriguing aspect of the surgical experience. This research has not only captivated the interest of other researchers, but has also expanded to include different disorders and age groups. The impact of accessing the dream state during anesthesia has been described as life-changing by individuals who have undergone this unique treatment, including my dear friend who has benefited from its effects. The exploration of dreaming during surgical anesthesia through the Shull-Chow method represents a fascinating intersection of science, innovation, and patient experience. As our understanding continues to evolve, this area of research holds promise for further advancements in anesthesia care and patient outcomes. #CRNA #Stanford #dreams

📢 We are excited to announce an exclusive upcoming Webinar: 💡 "Low-Field MRI: Real-Life Case Studies and Expert Insights" with expert radiologist Dr. E Knopp, Chief Medical Officer at Hyperfine, on October 23 at 6 PM CET. This webinar will provide a unique opportunity to explore the real-world applications of low-field MRI with an emphasis on pediatric neuroimaging applications and gain expert guidance on best practices. 🩻 This webinar will include: 1️⃣ A collection of real-life low-field MRI cases generously donated by our community. 2️⃣ In-depth discussion on GC guidance, incidental findings, and successful and challenging cases. 3️⃣ A live Q&A session with our panel of experts, Dr. Edmond Knopp, Sean Deoni, and Steve Williams, where you can get your specific questions answered. 👉 Click here to sign up for the webinar: https://lnkd.in/ddD_zSsy We hope to see you there! 🙌 🧲 Read the newly published article about UNITY: a low-field magnetic resonance neuroimaging initiative to characterize neurodevelopment in low and middle-income settings. 🔗 Read more here: https://lnkd.in/dzQwDeM3